S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NLTX Neoleukin Therapeutics Inc

3.49

0.00 (0.00%)

Pre Market

Last Updated: 11:00:00

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Neoleukin Therapeutics Charts.

Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Neoleukin Therapeutics Charts.

Neoleukin Therapeutics Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 10 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 9 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 21 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 19 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 3 June 2024 (6 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 11 May 2024 (7 months ago) • Edgar (US Regulatory)

More Neoleukin Therapeutics Inc News Articles

Commonwealth Bank Of Aus...

Australia And New Zealan...

Newcrest Mining

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions